BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17823929)

  • 1. ArrayCGH-based classification of neuroblastoma into genomic subgroups.
    Michels E; Vandesompele J; De Preter K; Hoebeeck J; Vermeulen J; Schramm A; Molenaar JJ; Menten B; Marques B; Stallings RL; Combaret V; Devalck C; De Paepe A; Versteeg R; Eggert A; Laureys G; Van Roy N; Speleman F
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1098-108. PubMed ID: 17823929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall genomic pattern is a predictor of outcome in neuroblastoma.
    Janoueix-Lerosey I; Schleiermacher G; Michels E; Mosseri V; Ribeiro A; Lequin D; Vermeulen J; Couturier J; Peuchmaur M; Valent A; Plantaz D; Rubie H; Valteau-Couanet D; Thomas C; Combaret V; Rousseau R; Eggert A; Michon J; Speleman F; Delattre O
    J Clin Oncol; 2009 Mar; 27(7):1026-33. PubMed ID: 19171713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
    Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
    Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide array-based comparative genomic hybridization (aCGH) of 90 neuroblastomas reveals aberration patterns closely associated with relapse pattern and outcome.
    Spitz R; Oberthuer A; Zapatka M; Brors B; Hero B; Ernestus K; Oestreich J; Fischer M; Simon T; Berthold F
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1130-42. PubMed ID: 16958102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
    Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
    Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.
    Selvarajah S; Yoshimoto M; Ludkovski O; Park PC; Bayani J; Thorner P; Maire G; Squire JA; Zielenska M
    Cytogenet Genome Res; 2008; 122(1):5-15. PubMed ID: 18931480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-mining of neuroblastoma and neuroblast gene expression profiles reveals candidate therapeutic compounds.
    De Preter K; De Brouwer S; Van Maerken T; Pattyn F; Schramm A; Eggert A; Vandesompele J; Speleman F
    Clin Cancer Res; 2009 Jun; 15(11):3690-6. PubMed ID: 19435837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma.
    Vandesompele J; Baudis M; De Preter K; Van Roy N; Ambros P; Bown N; Brinkschmidt C; Christiansen H; Combaret V; Lastowska M; Nicholson J; O'Meara A; Plantaz D; Stallings R; Brichard B; Van den Broecke C; De Bie S; De Paepe A; Laureys G; Speleman F
    J Clin Oncol; 2005 Apr; 23(10):2280-99. PubMed ID: 15800319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
    Jönsson G; Dahl C; Staaf J; Sandberg T; Bendahl PO; Ringnér M; Guldberg P; Borg A
    Oncogene; 2007 Jul; 26(32):4738-48. PubMed ID: 17260012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution cDNA microarray-based comparative genomic hybridization analysis in neuroblastoma.
    Chen QR; Bilke S; Khan J
    Cancer Lett; 2005 Oct; 228(1-2):71-81. PubMed ID: 15951107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization.
    Scaruffi P; Coco S; Cifuentes F; Albino D; Nair M; Defferrari R; Mazzocco K; Tonini GP
    Cancer Genet Cytogenet; 2007 Aug; 177(1):20-9. PubMed ID: 17693187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era.
    Mosse YP; Greshock J; Weber BL; Maris JM
    Cancer Lett; 2005 Oct; 228(1-2):83-90. PubMed ID: 15967571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of segmental alterations determines progression in neuroblastoma.
    Schleiermacher G; Janoueix-Lerosey I; Ribeiro A; Klijanienko J; Couturier J; Pierron G; Mosseri V; Valent A; Auger N; Plantaz D; Rubie H; Valteau-Couanet D; Bourdeaut F; Combaret V; Bergeron C; Michon J; Delattre O
    J Clin Oncol; 2010 Jul; 28(19):3122-30. PubMed ID: 20516441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-cost dedicated mini-arrays for high-throughput analysis of DNA copy-number alterations in neuroblastoma.
    De Preter K; Menten B; De Brouwer S; Kumps C; Michels E; Van Roy N; Vandesompele J; Speleman F
    Cancer Lett; 2008 Sep; 269(1):111-6. PubMed ID: 18555593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
    Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
    Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome complexity in acute lymphoblastic leukemia is revealed by array-based comparative genomic hybridization.
    Strefford JC; Worley H; Barber K; Wright S; Stewart AR; Robinson HM; Bettney G; van Delft FW; Atherton MG; Davies T; Griffiths M; Hing S; Ross FM; Talley P; Saha V; Moorman AV; Harrison CJ
    Oncogene; 2007 Jun; 26(29):4306-18. PubMed ID: 17237825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
    Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
    Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphism array analysis to predict clinical outcome in neuroblastoma patients.
    Hiyama E; Yamaoka H; Kamimatsuse A; Onitake Y; Hiyama K; Nishiyama M; Sueda T
    J Pediatr Surg; 2006 Dec; 41(12):2032-6. PubMed ID: 17161199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx.
    Järvinen AK; Autio R; Kilpinen S; Saarela M; Leivo I; Grénman R; Mäkitie AA; Monni O
    Genes Chromosomes Cancer; 2008 Jun; 47(6):500-9. PubMed ID: 18314910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.